Company news
Frontier Biotechnologies Inc. news in 2025
Frontier Biotechnologies Inc.'s news releases, calls and decks from 2025, newest first.
Announcement on Resolutions of the 9th Meeting of the 4th Board of Directors
December 11, 2025
Announcement on Election of Employee Directors for the 4th Board of Directors
November 19, 2025
Announcement on Convening the Q3 2025 Performance Briefing
October 30, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
October 9, 2025
Publicity Description and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on the List of Incentive Objects Initially Granted in the 2025 Restricted Stock Incentive Plan
September 29, 2025
Announcement on Resolutions of the 6th Meeting of the 4th Board of Supervisors
September 17, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
September 16, 2025
Announcement on Repayment of Previously Temporarily Used Raised Funds for Working Capital and Continued Use of Partial Idle Raised Funds to Temporarily Supplement Working Capital
September 11, 2025
Announcement on Changing Some Investment Projects Financed by Raised Funds
August 29, 2025
Announcement on Resolutions of the 3rd Meeting of the 4th Board of Supervisors
July 18, 2025
Announcement on Reply to the Regulatory Inquiry Letter on Information Disclosure of 2024 Annual Report
June 20, 2025
Announcement on Change of Sponsor Representative
May 26, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 23, 2025
Announcement on Signing the Supplementary Agreement and Passive Extension of Related Party Loans
April 29, 2025
Announcement on Attending the Annual Collective Performance Briefing for Innovative Drug Companies on SSE STAR Market 2024 and Convening the Q1 2025 Performance Briefing
April 27, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Announcement on Voluntary Disclosure of the Notice of Acceptance for Registration and Marketing License of FB3002 Loxoprofen Sodium Patches Obtained for Drug Manufactured in China
January 20, 2025
Voluntary Disclosure Announcement on Approval of Phase II Clinical Trial for New Indication of Immune Reconstitution Insufficient of Aikening
January 17, 2025